Aster DM Healthcare Limited
Financial trend (88/100) does the heavy lifting; valuation (4/100) is the drag.
ExpensiveOvervaluedAster DM Healthcare Limited earns a Hold from StocksWizard, with a blended score of 45/100. On 119.7x trailing earnings it sits pricier than the Healthcare median of about 37.6x. It's trading right at its 52-week high of ₹824.6. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. The average analyst target of ₹795.27 implies about 3% downside across 11 analysts. It clears 8 of 13 investability checks, with durability 55, valuation 7 and momentum 87 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹347.46.
Analyst views
1-year price
EOD · 2026-07-2952-week range
-0.76% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 10.1%
- Pass: Low debt (D/E < 0.5): 0.46x
- Pass: Positive free cash flow
- Pass: Revenue growth > 10%: 18%
- Pass: Earnings growing: 72%
- Fail: Net margin ≥ 10%: 8.4%
- Pass: Current ratio > 1.5: 1.99
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 8.94
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter53.3%
- Institutions34.3%
- Public & other12.4%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Trading near its 52-week high.
- Financially solid — Altman Z 8.94.
Opportunities
- Earnings growing (72% YoY).
- Revenue growing (18% YoY).
Bear case
Threats
- Rich valuation versus sector peers.
- Trades ~47% above our estimated fair value.
About Aster DM Healthcare Limited
Aster DM Healthcare operates a network of hospitals and clinics across India, supported by in-house and wholesale pharmacies. The company's business segments include hospital operations, clinic services, wholesale pharmacy distribution, and other healthcare services. It maintains pharmacies at its hospital and clinic facilities to serve patient needs.
Aster DM Healthcare Limited — frequently asked questions
Is Aster DM Healthcare Limited a buy, hold or sell?
StocksWizard currently rates Aster DM Healthcare Limited (ASTERDM) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Aster DM Healthcare Limited's fair value?
Our blended DCF and relative-valuation model estimates Aster DM Healthcare Limited's fair value at about ₹434.33, versus a current price of ₹818.35 — roughly 47% downside. On that basis the stock looks overvalued by 47%.
Is Aster DM Healthcare Limited financially healthy?
Aster DM Healthcare Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has Aster DM Healthcare Limited's share price performed?
Aster DM Healthcare Limited is up 17% over three months, and last traded at ₹818.35. Past performance doesn't predict future returns.
More in Healthcare
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.